Intermolecular, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 67,406 66,827 53,830 42,674
Cost of Revenue 32,485 28,403 25,469 20,926
Gross Profit 34,921 38,424 28,361 21,748
Operating Expenses
Research and Development 24,502 21,839 19,260 13,917
Sales, General and Admin. 18,448 16,301 12,819 9,835
Non-Recurring Items - - - -
Other - - - -
Operating Income (8,029) 284 (3,718) (2,004)
Income From Continuing Operations
Add'l Income/Expense Items 57 15 (26,167) 202
Earnings Before Interest and Tax (7,972) 299 (29,885) (1,759)
Interest Expense 830 1,004 87 -
Earnings Before Tax (8,802) (705) (29,972) (1,759)
Income Tax 17 51 43 19
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (8,819) (756) (30,015) (1,778)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (8,819) (756) (30,015) (1,778)
Preferred Stock and Other Adjustments - - (8,660) (14,162)
Net Income Applicable to Common Shareholders (8,819) (756) (38,675) (15,940)